Thoracic Radiation Therapy

RADIATION6 trials

Sponsors

First People's Hospital of Hangzhou, H. Lee Moffitt Cancer Center and Research Institute, Wuhan University, SWOG Cancer Research Network, Yayi He

Conditions

Carcinoma, Non-Small-Cell LungCarcinoma, Squamous CellExtensive Stage Lung Small Cell CarcinomaExtensive-stage Small Cell Lung CancerLimited-stage Small Cell Lung Cancer (LS-SCLC)Lung Small Cell Carcinoma, A SubtypeLung Small Cell Carcinoma, I SubtypeLung Small Cell Carcinoma, N Subtype

Phase 1

Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer

CompletedNCT03043599

H. Lee Moffitt Cancer Center and Research InstituteExtensive-stage Small Cell Lung Cancer, Small Cell Lung Cancer

Start: 2017-02-13End: 2023-11-16Updated: 2024-12-20

Phase 2

Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer

First People's Hospital of HangzhouCarcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell

Start: 2012-07-31End: 2017-06-30Target: 21Updated: 2015-12-15

A Study of Pemetrexed Plus Cisplatin With Concurrent Radiation Therapy Followed by Docetaxel Consolidation in Patients With Inoperable Squamous Cell Lung Cancer

First People's Hospital of HangzhouSquamous Cell Lung Cancer

Start: 2016-10-31End: 2020-09-30Target: 54Updated: 2016-11-25

Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer

TerminatedNCT03802058

Wuhan UniversityCarcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma

Start: 2019-03-20End: 2021-12-12Updated: 2023-04-28

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

RecruitingNCT06769126

SWOG Cancer Research NetworkExtensive Stage Lung Small Cell Carcinoma, Lung Small Cell Carcinoma, A Subtype, Lung Small Cell Carcinoma, I Subtype +2

Start: 2025-11-06End: 2029-12-31Target: 900Updated: 2026-03-30

Benmelstobart Plus Anlotinib, Chemotherapy and Thoracic Radiation for Limited-Stage Small Cell Lung Cancer

Not yet recruitingNCT07538258

Yayi HeLimited-stage Small Cell Lung Cancer (LS-SCLC)

Start: 2026-04-20End: 2029-03-31Target: 27Updated: 2026-04-20